News items Depressive symptoms during pregnancy affect baby
16 September 2021

Depression or depressive symptoms during pregnancy may lead to a bad start for the infant, such as a preterm birth. Researchers of Radboud university medical center found that this was true for both women who were treated with antidepressants and those who received no medication. The researchers conducted a large meta-analysis in which they examined individual-level participant data of 400,000 women internationally.

About ten percent of women experience depression or depressive symptoms during pregnancy. Epidemiologist Marleen van Gelder of Radboud university medical center: "We noticed a lot of attention in the society for postpartum depression, so when the baby is born. Feelings of depression during pregnancy are less visible, but our study shows that a significant group of women suffers from it and that this can have consequences for the baby."

For this study, data from over 400,000 participants from 27 different studies were pooled and analyzed to gain more insight into the association between depressive symptoms during pregnancy, antidepressant use, and the risk of a number of common negative health outcomes for the baby: preterm birth, low birth weight (less than 2,500 grams), small-for-gestational age, and a low Apgar score (a test that measures the health of the baby immediately after birth).

It appears that women with (symptoms of) depression have an increased risk of preterm birth and a baby with a low Apgar score, even when no antidepressants were used. The use of certain antidepressants gave even a slightly higher risk. No increased risks of having a child with a low birth weight or small-for-gestational age were observed, neither in the group of women who did not use or did use antidepressants.

Marleen van Gelder: "Based on these results, we conclude that depression during pregnancy should not be left untreated, since most of the increased risks were also seen among women with depression who did not use antidepressants. This information can help health care providers and pregnant women in making the decision whether the positive effects of treatment outweigh the potential risks to the unborn child."

About the study in Obstetrics & Gynecology

Associations Between Maternal Depression, Antidepressant Use During Pregnancy, and Adverse Pregnancy Outcomes: An Individual Participant Data Meta-analysis - Richelle Vlenterie, Marleen M. H. J. van Gelder, [...], Judith B. Prins, Monica Pop-Purceleanu, and Nel Roeleveld.

More information

Pauline Dekhuijzen

wetenschaps- en persvoorlichter

neem contact op

Related news items

1.5 million euro grant for research into earlier recognition of Parkinson's disease

27 October 2021

Researchers aim to improve identification of early symptoms and subtypes of Parkinson's disease with large international study

read more

BRAINMODEL: precision medicine for brain disorders

25 October 2021

A team of researchers from Radboudumc, VU Amsterdam and other institutes is going to look for new and better ways to heal developmental disorders in the brain.

read more

Christian Gilissen appointed professor of Genome Bioinformatics

22 October 2021

Christian Gilissen has been appointed Professor of Genome Bioinformatics at the Radboudumc / Radboud University as of 1 October 2021.

read more

How healthy is James Bond? - A flu to a kill No time to die: the pathogens surrounding secret agent 007

21 October 2021

James Bond made a total of 25 films between 1962 and 2021. In all those films, secret agent 007 washed his hands only twice, even though he often stayed in not so hygienic places with considerable health risks. Radboudumc researchers examined all the health risks in the 47 countries Bond visited.

read more